Page last updated: 2024-10-29

amrinone and Drug Withdrawal Symptoms

amrinone has been researched along with Drug Withdrawal Symptoms in 1 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"Eighteen patients with congestive heart failure were studied in a double-blind, randomized, placebo-controlled withdrawal trial to evaluate the effectiveness of chronic oral amrinone therapy when added to conventional heart failure therapy."9.05Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study. ( Bashore, TM; Evans, JR; Huss, P; Leier, CV; Pacht, K; Unverferth, DV, 1984)
"Eighteen patients with congestive heart failure were studied in a double-blind, randomized, placebo-controlled withdrawal trial to evaluate the effectiveness of chronic oral amrinone therapy when added to conventional heart failure therapy."5.05Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study. ( Bashore, TM; Evans, JR; Huss, P; Leier, CV; Pacht, K; Unverferth, DV, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, JR1
Pacht, K1
Huss, P1
Unverferth, DV1
Bashore, TM1
Leier, CV1

Trials

1 trial available for amrinone and Drug Withdrawal Symptoms

ArticleYear
Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
    International journal of clinical pharmacology research, 1984, Volume: 4, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aminopyridines; Amrinone; Cardiotonic Agents; Clinical Trials as

1984